FDA Import Refusal M21-0750389-0/1/1 — Xellia Pharmaceuticals ApS
The FDA refused shipment M21-0750389-0/1/1 from Xellia Pharmaceuticals ApS (Denmark) on August 1, 2014. The refused product falls under Drugs and Biologics — BACITRACIN ZINC CATEGORY I, TYPE A MEDICATED ARTICLE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 1, 2014
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 67A08 BACITRACIN ZINC CATEGORY I, TYPE A MEDICATED ARTICLE
- Charges
- 75